Tan Shidong, Zang Guangyao, Wang Ying, Sun Zhen, Li Yalan, Lu Cheng, Wang Zhongqun
Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, People's Republic of China.
General Office, Affiliated Hospital of Jiangsu University, Zhenjiang, People's Republic of China.
Diabetes Metab Syndr Obes. 2021 Jul 24;14:3375-3388. doi: 10.2147/DMSO.S315362. eCollection 2021.
Angiogenesis, as a process occurring under the regulation of a variety of factors, is one of the important ways of vascular development. It coexists in a variety of pathological and physiological processes. Now a large number of studies have proved that tumor growth, metastasis, and various vascular complications of diabetes are closely related to angiogenesis, and an increasing number of studies have shown that there are many common factors between the two. But angiogenesis is the opposite of the two: it is enhanced in tumors and suppressed in diabetes. Therefore, this review discusses the causes of the phenomenon from the expression of various factors affecting angiogenesis in these two diseases and their effects on angiogenesis in the relevant microenvironment, as well as the application status of these factors or cells as therapeutic targets in the treatment of these two diseases.
血管生成作为在多种因素调控下发生的过程,是血管发育的重要方式之一。它存在于多种病理和生理过程中。目前大量研究已证明,肿瘤生长、转移以及糖尿病的各种血管并发症都与血管生成密切相关,并且越来越多的研究表明两者之间存在许多共同因素。但在这两种情况中血管生成却是相反的:在肿瘤中增强而在糖尿病中受到抑制。因此,本综述从影响这两种疾病中血管生成的各种因素的表达及其在相关微环境中对血管生成的作用来探讨该现象的成因,以及这些因素或细胞作为治疗靶点在这两种疾病治疗中的应用现状。